Stem definition | Drug id | CAS RN |
---|---|---|
4200 | 7786-30-3 |
Molecule | Description |
---|---|
Synonyms:
|
Magnesium chloride. An inorganic compound consisting of one magnesium and two chloride ions. The compound is used in medicine as a source of magnesium ions, which are essential for many cellular activities. It has also been used as a cathartic and in alloys.
|
Dose | Unit | Route |
---|---|---|
2.50 | g | O |
0.80 | g | P |
None
Date | Agency | Company | Orphan |
---|---|---|---|
Aug. 13, 1975 | FDA | HOSPIRA |
MedDRA adverse event term | Likelihood ratio | Likelihood ratio threshold | Patients taking drug having adverse event | Patients taking drug not having adverse event | Patients not taking drug having adverse event | Patients not taking drug not having adverse event |
---|---|---|---|---|---|---|
Death | 672.79 | 18.76 | 436 | 5573 | 324943 | 50274172 |
Peritonitis bacterial | 543.47 | 18.76 | 123 | 5886 | 4538 | 50594577 |
Peritonitis | 367.69 | 18.76 | 116 | 5893 | 15370 | 50583745 |
Peritoneal dialysis complication | 346.85 | 18.76 | 67 | 5942 | 1114 | 50598001 |
Toxic anterior segment syndrome | 339.86 | 18.76 | 69 | 5940 | 1496 | 50597619 |
Fungal peritonitis | 227.48 | 18.76 | 41 | 5968 | 456 | 50598659 |
Device interaction | 167.32 | 18.76 | 28 | 5981 | 193 | 50598922 |
Sepsis | 144.22 | 18.76 | 122 | 5887 | 132803 | 50466312 |
Endophthalmitis | 136.30 | 18.76 | 37 | 5972 | 2879 | 50596236 |
Encapsulating peritoneal sclerosis | 91.97 | 18.76 | 18 | 5991 | 320 | 50598795 |
Ultrafiltration failure | 88.09 | 18.76 | 16 | 5993 | 186 | 50598929 |
Peritoneal cloudy effluent | 65.57 | 18.76 | 11 | 5998 | 77 | 50599038 |
Hypervolaemia | 63.81 | 18.76 | 39 | 5970 | 25460 | 50573655 |
Cardiac disorder | 53.87 | 18.76 | 43 | 5966 | 42936 | 50556179 |
Cardiovascular disorder | 51.36 | 18.76 | 25 | 5984 | 10429 | 50588686 |
Post procedural complication | 50.80 | 18.76 | 28 | 5981 | 15076 | 50584039 |
Tonsillar haemorrhage | 48.36 | 18.76 | 10 | 5999 | 237 | 50598878 |
Anterior chamber inflammation | 46.65 | 18.76 | 10 | 5999 | 283 | 50598832 |
Cardiac arrest | 45.83 | 18.76 | 53 | 5956 | 83598 | 50515517 |
Myocardial infarction | 44.79 | 18.76 | 54 | 5955 | 88973 | 50510142 |
Drug ineffective | 43.06 | 18.76 | 22 | 5987 | 819311 | 49779804 |
Bloody peritoneal effluent | 41.85 | 18.76 | 7 | 6002 | 48 | 50599067 |
Gangrene | 41.69 | 18.76 | 17 | 5992 | 4675 | 50594440 |
Cardiac failure | 39.69 | 18.76 | 47 | 5962 | 75993 | 50523122 |
Marasmus | 37.40 | 18.76 | 9 | 6000 | 431 | 50598684 |
Cataract operation complication | 36.23 | 18.76 | 7 | 6002 | 116 | 50598999 |
Cerebrovascular accident | 33.03 | 18.76 | 48 | 5961 | 94632 | 50504483 |
Hypoglycaemia | 32.83 | 18.76 | 36 | 5973 | 53545 | 50545570 |
Anterior chamber disorder | 32.13 | 18.76 | 6 | 6003 | 82 | 50599033 |
Diabetic complication | 27.59 | 18.76 | 8 | 6001 | 790 | 50598325 |
Hypoglycaemic coma | 26.15 | 18.76 | 10 | 5999 | 2323 | 50596792 |
Noninfectious peritonitis | 23.48 | 18.76 | 5 | 6004 | 137 | 50598978 |
Pulmonary oedema | 23.47 | 18.76 | 29 | 5980 | 48909 | 50550206 |
Pneumonia | 22.81 | 18.76 | 97 | 5912 | 378304 | 50220811 |
Dermatitis exfoliative | 21.42 | 18.76 | 11 | 5998 | 5131 | 50593984 |
Abdominal distension | 21.22 | 18.76 | 34 | 5975 | 72869 | 50526246 |
Faeces soft | 20.76 | 18.76 | 10 | 5999 | 4074 | 50595041 |
Hypotension | 20.53 | 18.76 | 68 | 5941 | 235401 | 50363714 |
Catheter site infection | 20.30 | 18.76 | 10 | 5999 | 4276 | 50594839 |
Diabetic foot | 19.77 | 18.76 | 7 | 6002 | 1311 | 50597804 |
Corneal oedema | 19.42 | 18.76 | 7 | 6002 | 1380 | 50597735 |
Joint swelling | 19.36 | 18.76 | 3 | 6006 | 245283 | 50353832 |
Blood glucose false positive | 19.29 | 18.76 | 3 | 6006 | 12 | 50599103 |
Amylase abnormal | 19.29 | 18.76 | 3 | 6006 | 12 | 50599103 |
Rash pruritic | 19.26 | 18.76 | 26 | 5983 | 47820 | 50551295 |
MedDRA adverse event term | Likelihood ratio | Likelihood ratio threshold | Patients taking drug having adverse event | Patients taking drug not having adverse event | Patients not taking drug having adverse event | Patients not taking drug not having adverse event |
---|---|---|---|---|---|---|
Peritonitis bacterial | 774.79 | 24.76 | 190 | 6028 | 5566 | 29562743 |
Death | 761.47 | 24.76 | 597 | 5621 | 341487 | 29226822 |
Peritonitis | 487.18 | 24.76 | 163 | 6055 | 14661 | 29553648 |
Peritoneal dialysis complication | 465.08 | 24.76 | 99 | 6119 | 1498 | 29566811 |
Fungal peritonitis | 326.01 | 24.76 | 64 | 6154 | 628 | 29567681 |
Toxic anterior segment syndrome | 283.25 | 24.76 | 61 | 6157 | 975 | 29567334 |
Device interaction | 136.67 | 24.76 | 30 | 6188 | 525 | 29567784 |
Cardiac disorder | 111.81 | 24.76 | 79 | 6139 | 37184 | 29531125 |
Encapsulating peritoneal sclerosis | 108.21 | 24.76 | 25 | 6193 | 556 | 29567753 |
Myocardial infarction | 107.91 | 24.76 | 124 | 6094 | 110172 | 29458137 |
Ultrafiltration failure | 107.82 | 24.76 | 20 | 6198 | 140 | 29568169 |
Cardiac failure | 96.39 | 24.76 | 100 | 6118 | 79187 | 29489122 |
Gangrene | 90.96 | 24.76 | 34 | 6184 | 4184 | 29564125 |
Peritoneal cloudy effluent | 85.28 | 24.76 | 16 | 6202 | 120 | 29568189 |
Noninfectious peritonitis | 79.89 | 24.76 | 15 | 6203 | 113 | 29568196 |
Hypervolaemia | 79.01 | 24.76 | 48 | 6170 | 17497 | 29550812 |
Post procedural complication | 75.70 | 24.76 | 39 | 6179 | 10350 | 29557959 |
Sepsis | 74.23 | 24.76 | 118 | 6100 | 142564 | 29425745 |
Cardiac arrest | 73.29 | 24.76 | 90 | 6128 | 85501 | 29482808 |
Endophthalmitis | 72.70 | 24.76 | 26 | 6192 | 2822 | 29565487 |
Cardiovascular disorder | 57.86 | 24.76 | 31 | 6187 | 8904 | 29559405 |
Catheter site infection | 57.38 | 24.76 | 20 | 6198 | 2012 | 29566297 |
Cataract operation complication | 47.24 | 24.76 | 10 | 6208 | 146 | 29568163 |
Bloody peritoneal effluent | 45.21 | 24.76 | 9 | 6209 | 95 | 29568214 |
Drug ineffective | 44.39 | 24.76 | 11 | 6207 | 363159 | 29205150 |
Peritoneal effluent abnormal | 38.66 | 24.76 | 7 | 6211 | 42 | 29568267 |
Hernia | 32.88 | 24.76 | 21 | 6197 | 8337 | 29559972 |
Blood glucose false positive | 31.98 | 24.76 | 6 | 6212 | 45 | 29568264 |
Cerebrovascular accident | 31.12 | 24.76 | 57 | 6161 | 76854 | 29491455 |
Localised infection | 29.62 | 24.76 | 24 | 6194 | 13792 | 29554517 |
Procedural pain | 28.24 | 24.76 | 15 | 6203 | 4229 | 29564080 |
Keratitis | 26.96 | 24.76 | 10 | 6208 | 1202 | 29567107 |
Peritoneal disorder | 26.82 | 24.76 | 7 | 6211 | 261 | 29568048 |
Toxicity to various agents | 26.11 | 24.76 | 3 | 6215 | 173658 | 29394651 |
Drug interaction | 26.03 | 24.76 | 5 | 6213 | 197380 | 29370929 |
Complication associated with device | 25.42 | 24.76 | 15 | 6203 | 5176 | 29563133 |
MedDRA adverse event term | Likelihood ratio | Likelihood ratio threshold | Patients taking drug having adverse event | Patients taking drug not having adverse event | Patients not taking drug having adverse event | Patients not taking drug not having adverse event |
---|---|---|---|---|---|---|
Peritonitis bacterial | 1040.30 | 17.46 | 240 | 8174 | 8803 | 64481515 |
Toxic anterior segment syndrome | 557.57 | 17.46 | 114 | 8300 | 2325 | 64487993 |
Peritonitis | 546.92 | 17.46 | 180 | 8234 | 24843 | 64465475 |
Peritoneal dialysis complication | 484.97 | 17.46 | 100 | 8314 | 2128 | 64488190 |
Death | 441.89 | 17.46 | 417 | 7997 | 482288 | 64008030 |
Fungal peritonitis | 334.77 | 17.46 | 64 | 8350 | 907 | 64489411 |
Device interaction | 240.56 | 17.46 | 46 | 8368 | 652 | 64489666 |
Endophthalmitis | 199.10 | 17.46 | 58 | 8356 | 5307 | 64485011 |
Encapsulating peritoneal sclerosis | 161.86 | 17.46 | 34 | 8380 | 791 | 64489527 |
Peritoneal cloudy effluent | 104.20 | 17.46 | 19 | 8395 | 204 | 64490114 |
Ultrafiltration failure | 102.11 | 17.46 | 19 | 8395 | 230 | 64490088 |
Sepsis | 101.59 | 17.46 | 137 | 8277 | 230204 | 64260114 |
Post procedural complication | 91.55 | 17.46 | 48 | 8366 | 21305 | 64469013 |
Gangrene | 88.40 | 17.46 | 34 | 8380 | 7304 | 64483014 |
Cataract operation complication | 87.67 | 17.46 | 17 | 8397 | 260 | 64490058 |
Cardiac arrest | 84.18 | 17.46 | 102 | 8312 | 153962 | 64336356 |
Noninfectious peritonitis | 70.97 | 17.46 | 14 | 8400 | 235 | 64490083 |
Hypervolaemia | 70.30 | 17.46 | 50 | 8364 | 38235 | 64452083 |
Myocardial infarction | 64.57 | 17.46 | 93 | 8321 | 165728 | 64324590 |
Cardiac disorder | 63.63 | 17.46 | 55 | 8359 | 55761 | 64434557 |
Blood glucose false positive | 55.73 | 17.46 | 9 | 8405 | 43 | 64490275 |
Drug ineffective | 52.74 | 17.46 | 22 | 8392 | 840225 | 63650093 |
Bloody peritoneal effluent | 51.20 | 17.46 | 10 | 8404 | 159 | 64490159 |
Catheter site infection | 46.63 | 17.46 | 20 | 8394 | 5673 | 64484645 |
Cardiac failure | 45.41 | 17.46 | 70 | 8344 | 132303 | 64358015 |
Complication associated with device | 40.56 | 17.46 | 25 | 8389 | 15055 | 64475263 |
Hypoglycaemia | 38.78 | 17.46 | 53 | 8361 | 89839 | 64400479 |
Peritoneal effluent abnormal | 36.29 | 17.46 | 6 | 8408 | 34 | 64490284 |
Abdominal distension | 34.65 | 17.46 | 52 | 8362 | 95942 | 64394376 |
Anterior chamber disorder | 34.42 | 17.46 | 7 | 8407 | 138 | 64490180 |
Drug interaction | 33.47 | 17.46 | 4 | 8410 | 362079 | 64128239 |
Peritoneal disorder | 33.09 | 17.46 | 9 | 8405 | 640 | 64489678 |
Diabetic complication | 32.11 | 17.46 | 10 | 8404 | 1145 | 64489173 |
Tonsillar haemorrhage | 30.48 | 17.46 | 7 | 8407 | 248 | 64490070 |
Procedural complication | 30.18 | 17.46 | 16 | 8398 | 7249 | 64483069 |
Toxicity to various agents | 29.12 | 17.46 | 6 | 8408 | 363507 | 64126811 |
Rash pruritic | 28.06 | 17.46 | 36 | 8378 | 57368 | 64432950 |
Pneumonia | 27.82 | 17.46 | 145 | 8269 | 559431 | 63930887 |
Hypoglycaemic coma | 25.40 | 17.46 | 12 | 8402 | 4262 | 64486056 |
Keratitis | 25.29 | 17.46 | 11 | 8403 | 3226 | 64487092 |
Multimorbidity | 24.97 | 17.46 | 8 | 8406 | 1004 | 64489314 |
Rash erythematous | 24.56 | 17.46 | 31 | 8383 | 48602 | 64441716 |
Lactobacillus test positive | 23.22 | 17.46 | 4 | 8410 | 30 | 64490288 |
Corneal disorder | 23.02 | 17.46 | 9 | 8405 | 2018 | 64488300 |
Blood loss anaemia | 22.88 | 17.46 | 17 | 8397 | 13875 | 64476443 |
Haemodialysis | 21.85 | 17.46 | 18 | 8396 | 17059 | 64473259 |
Corneal oedema | 21.75 | 17.46 | 9 | 8405 | 2334 | 64487984 |
Amylase abnormal | 21.68 | 17.46 | 4 | 8410 | 46 | 64490272 |
Cerebrovascular accident | 21.33 | 17.46 | 52 | 8362 | 137531 | 64352787 |
Device related infection | 21.28 | 17.46 | 23 | 8391 | 30603 | 64459715 |
Peritoneal fluid analysis abnormal | 20.96 | 17.46 | 4 | 8410 | 56 | 64490262 |
Staphylococcal infection | 20.52 | 17.46 | 29 | 8385 | 50649 | 64439669 |
Failure to thrive | 20.04 | 17.46 | 14 | 8400 | 10390 | 64479928 |
Eastern Cooperative Oncology Group performance status worsened | 19.49 | 17.46 | 7 | 8407 | 1241 | 64489077 |
Regurgitation | 19.24 | 17.46 | 8 | 8406 | 2101 | 64488217 |
Product complaint | 18.30 | 17.46 | 14 | 8400 | 11940 | 64478378 |
Intraocular pressure increased | 17.95 | 17.46 | 12 | 8402 | 8290 | 64482028 |
Dermatitis exfoliative | 17.80 | 17.46 | 13 | 8401 | 10339 | 64479979 |
Peritoneal effluent leukocyte count increased | 17.48 | 17.46 | 3 | 8411 | 22 | 64490296 |
None
Source | Code | Description |
---|---|---|
ATC | A12CC01 | ALIMENTARY TRACT AND METABOLISM MINERAL SUPPLEMENTS OTHER MINERAL SUPPLEMENTS Magnesium |
ATC | B05XA11 | BLOOD AND BLOOD FORMING ORGANS BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS I.V. SOLUTION ADDITIVES Electrolyte solutions |
Disease | Relation | SNOMED_ID | DOID |
---|---|---|---|
Hypomagnesemia | indication | 190855004 | |
Anuria | contraindication | 2472002 | DOID:2983 |
Hypocalcemia | contraindication | 5291005 | |
Classical phenylketonuria | contraindication | 7573000 | |
Poisoning by digitalis glycoside | contraindication | 12876009 | |
Hyperkalemia | contraindication | 14140009 | |
Complete atrioventricular block | contraindication | 27885002 | |
Sarcoidosis | contraindication | 31541009 | DOID:11335 |
End stage renal disease | contraindication | 46177005 | DOID:784 |
Humoral hypercalcemia of malignancy | contraindication | 47709007 | |
Heart disease | contraindication | 56265001 | DOID:114 |
Congenital myotonia, autosomal dominant form | contraindication | 57938005 | |
Acute nephropathy | contraindication | 58574008 | |
Diarrhea | contraindication | 62315008 | |
Hypercalcemia | contraindication | 66931009 | DOID:12678 |
Hypermagnesemia | contraindication | 66978005 | |
Ventricular fibrillation | contraindication | 71908006 | |
Hypercalciuria | contraindication | 71938000 | |
Hyperchloremia | contraindication | 74450001 | |
Third degree burn injury | contraindication | 80247002 | |
Oliguria | contraindication | 83128009 | |
Kidney disease | contraindication | 90708001 | DOID:557 |
Kidney stone | contraindication | 95570007 | |
Hyporeninemic hypoaldosteronism | contraindication | 236464008 | |
Familial hyperkalemic periodic paralysis | contraindication | 304737009 | DOID:14451 |
Azotemia | contraindication | 445009001 | |
Severe dehydration | contraindication | 450316000 |
None
None
None
Formulation strength | Trade name | Applicant | Application number | Approval date | Type | Dose form | Route | Patent number | Patent expiration date | Patent use |
---|---|---|---|---|---|---|---|---|---|---|
0.21GM/100ML;2.8GM/100ML;9.07GM/100ML | NORMOCARB HF 25 | DIALYSIS SUPS | N021910 | July 26, 2006 | RX | SOLUTION | INJECTION | 7300674 | March 4, 2023 | USE AS REPLACEMENT SOLUTION, HEMOFILTRATION SOLUTION OR HEMODIAFILTRATION SOLUTION IN CONTINUOUS RENAL REPLACEMENT THERAPY |
Formulation strength | Trade name | Applicant | Application number | Approval date | Type | Dose form | Route | Exclusivity date | Description |
---|---|---|---|---|---|---|---|---|---|
3.68GM/1000ML;3.05GM/1000ML;0.314GM/1000ML ;3.09GM/1000ML;6.34GM/1000ML;0.187GM/1000ML (5000ML) | PHOXILLUM BK 4/2.5 IN PLASTIC CONTAINER | BAXTER HLTHCARE CORP | N207026 | Jan. 13, 2015 | RX | INJECTABLE | INJECTION | Jan. 13, 2022 | AS A REPLACEMENT SOLUTION IN CONTINUOUS RENAL REPLACEMENT THERAPY (CRRT) AND IN CASE OF DRUG POISONING WHEN CRRT IS USED TO REMOVE DIALYZABLE SUBSTANCES |
N/A/1000ML;3.05GM/1000ML;0.314GM/1000ML;2.21GM/1000ML;6.95GM/1000ML;0.187GM/1000ML (5000ML) | PHOXILLUM B22K 4/0 IN PLASTIC CONTAINER | BAXTER HLTHCARE CORP | N207026 | Jan. 13, 2015 | RX | INJECTABLE | INJECTION | Jan. 13, 2022 | AS A REPLACEMENT SOLUTION IN CONTINUOUS RENAL REPLACEMENT THERAPY (CRRT) AND IN CASE OF DRUG POISONING WHEN CRRT IS USED TO REMOVE DIALYZABLE SUBSTANCES |
None
ID | Source |
---|---|
4018213 | VUID |
N0000146546 | NUI |
D04834 | KEGG_DRUG |
4018213 | VANDF |
C0024472 | UMLSCUI |
CHEBI:86345 | CHEBI |
CHEMBL2219642 | ChEMBL_ID |
CHEMBL3185229 | ChEMBL_ID |
D015636 | MESH_DESCRIPTOR_UI |
DB09407 | DRUGBANK_ID |
02F3473H9O | UNII |
46835706 | PUBCHEM_CID |
6579 | RXNORM |
5007 | MMSL |
5009 | MMSL |
71973 | MMSL |
d03796 | MMSL |
000786 | NDDF |
45733002 | SNOMEDCT_US |
768454005 | SNOMEDCT_US |
7791-18-6 | SECONDARY_CAS_RN |
Product | Category | Ingredients | NDC | Form | Quantity | Route | Marketing | Label |
---|---|---|---|---|---|---|---|---|
BSS | HUMAN PRESCRIPTION DRUG LABEL | 6 | 0065-0795 | SOLUTION | 0.30 mg | OPHTHALMIC | NDA | 9 sections |
BSS | HUMAN PRESCRIPTION DRUG LABEL | 6 | 0065-0795 | SOLUTION | 0.30 mg | OPHTHALMIC | NDA | 9 sections |
BSS | HUMAN PRESCRIPTION DRUG LABEL | 6 | 0065-1795 | SOLUTION | 0.30 mg | OPHTHALMIC | NDA | 9 sections |
HyperlyteCR | HUMAN PRESCRIPTION DRUG LABEL | 5 | 0264-1943 | INJECTION, SOLUTION, CONCENTRATE | 0.51 g | INTRAVENOUS | UNAPPROVED DRUG OTHER | 18 sections |
HyperlyteCR | HUMAN PRESCRIPTION DRUG LABEL | 5 | 0264-1943 | INJECTION, SOLUTION, CONCENTRATE | 0.51 g | INTRAVENOUS | UNAPPROVED DRUG OTHER | 18 sections |
Balanced Salt | HUMAN PRESCRIPTION DRUG LABEL | 6 | 0264-1945 | SOLUTION | 0.30 mg | IRRIGATION | ANDA | 11 sections |
Physiolyte | HUMAN PRESCRIPTION DRUG LABEL | 5 | 0264-2205 | IRRIGANT | 0.03 g | IRRIGATION | NDA | 20 sections |
Physiolyte | HUMAN PRESCRIPTION DRUG LABEL | 5 | 0264-2205 | IRRIGANT | 0.03 g | IRRIGATION | NDA | 20 sections |
Balanced Salt | HUMAN PRESCRIPTION DRUG LABEL | 6 | 0264-2514 | SOLUTION | 0.30 mg | IRRIGATION | ANDA | 11 sections |
Isolyte S | HUMAN PRESCRIPTION DRUG LABEL | 5 | 0264-7703 | INJECTION, SOLUTION | 0.03 g | INTRAVENOUS | NDA | 19 sections |
Isolyte S | HUMAN PRESCRIPTION DRUG LABEL | 5 | 0264-7703 | INJECTION, SOLUTION | 0.03 g | INTRAVENOUS | NDA | 19 sections |
Isolyte S pH 7.4 | HUMAN PRESCRIPTION DRUG LABEL | 7 | 0264-7707 | INJECTION, SOLUTION | 0.03 g | INTRAVENOUS | NDA | 24 sections |
Isolyte S pH 7.4 | HUMAN PRESCRIPTION DRUG LABEL | 7 | 0264-7707 | INJECTION, SOLUTION | 0.03 g | INTRAVENOUS | NDA | 24 sections |
Isolyte P in Dextrose | HUMAN PRESCRIPTION DRUG LABEL | 5 | 0264-7730 | INJECTION, SOLUTION | 0.03 g | INTRAVENOUS | NDA | 23 sections |
Isolyte P in Dextrose | HUMAN PRESCRIPTION DRUG LABEL | 5 | 0264-7730 | INJECTION, SOLUTION | 0.03 g | INTRAVENOUS | NDA | 23 sections |
Dextrose and Electrolyte No. 48 | HUMAN PRESCRIPTION DRUG LABEL | 6 | 0338-0143 | INJECTION | 31 mg | INTRAVENOUS | NDA | 19 sections |
Dextrose and Electrolyte No. 48 | HUMAN PRESCRIPTION DRUG LABEL | 6 | 0338-0143 | INJECTION | 31 mg | INTRAVENOUS | NDA | 19 sections |
Plasma-Lyte 148 | HUMAN PRESCRIPTION DRUG LABEL | 5 | 0338-0179 | INJECTION, SOLUTION | 30 mg | INTRAVENOUS | NDA | 20 sections |
Plasma-Lyte 148 | HUMAN PRESCRIPTION DRUG LABEL | 5 | 0338-0179 | INJECTION, SOLUTION | 30 mg | INTRAVENOUS | NDA | 20 sections |
CLINIMIX E | HUMAN PRESCRIPTION DRUG LABEL | 21 | 0338-0202 | INJECTION | 51 mg | INTRAVENOUS | NDA | 20 sections |
CLINIMIX E | HUMAN PRESCRIPTION DRUG LABEL | 21 | 0338-0202 | INJECTION | 51 mg | INTRAVENOUS | NDA | 20 sections |
CLINIMIX E | HUMAN PRESCRIPTION DRUG LABEL | 21 | 0338-0206 | INJECTION | 51 mg | INTRAVENOUS | NDA | 20 sections |
CLINIMIX E | HUMAN PRESCRIPTION DRUG LABEL | 21 | 0338-0206 | INJECTION | 51 mg | INTRAVENOUS | NDA | 20 sections |
CLINIMIX E | HUMAN PRESCRIPTION DRUG LABEL | 21 | 0338-0210 | INJECTION | 51 mg | INTRAVENOUS | NDA | 20 sections |
CLINIMIX E | HUMAN PRESCRIPTION DRUG LABEL | 21 | 0338-0210 | INJECTION | 51 mg | INTRAVENOUS | NDA | 20 sections |
CLINIMIX E | HUMAN PRESCRIPTION DRUG LABEL | 21 | 0338-0214 | INJECTION | 51 mg | INTRAVENOUS | NDA | 20 sections |
CLINIMIX E | HUMAN PRESCRIPTION DRUG LABEL | 21 | 0338-0214 | INJECTION | 51 mg | INTRAVENOUS | NDA | 20 sections |
Plasma-Lyte A | HUMAN PRESCRIPTION DRUG LABEL | 5 | 0338-0221 | INJECTION, SOLUTION | 30 mg | INTRAVENOUS | NDA | 19 sections |
Plasma-Lyte A | HUMAN PRESCRIPTION DRUG LABEL | 5 | 0338-0221 | INJECTION, SOLUTION | 30 mg | INTRAVENOUS | NDA | 19 sections |
Cardioplegic | HUMAN PRESCRIPTION DRUG LABEL | 4 | 0338-0341 | SOLUTION | 325.30 mg | INTRA-ARTERIAL | ANDA | 15 sections |